XBiotech Inc.
XBIT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -78.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 83.8% | 68.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -794.9% | -122% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -820.4% | -94.7% |
| EPS Diluted | -1.26 | -0.81 | -1.08 | -0.58 |
| % Growth | -55.6% | 25% | -86.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |